ATE464383T1 - Tumor antigen - Google Patents

Tumor antigen

Info

Publication number
ATE464383T1
ATE464383T1 AT00949982T AT00949982T ATE464383T1 AT E464383 T1 ATE464383 T1 AT E464383T1 AT 00949982 T AT00949982 T AT 00949982T AT 00949982 T AT00949982 T AT 00949982T AT E464383 T1 ATE464383 T1 AT E464383T1
Authority
AT
Austria
Prior art keywords
peptide
entities
tumor antigen
restricted
recombinant vector
Prior art date
Application number
AT00949982T
Other languages
English (en)
Inventor
Kyogo Itoh
Original Assignee
Greenpeptide Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Greenpeptide Co Ltd filed Critical Greenpeptide Co Ltd
Application granted granted Critical
Publication of ATE464383T1 publication Critical patent/ATE464383T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT00949982T 1999-08-05 2000-08-03 Tumor antigen ATE464383T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP22210199 1999-08-05
PCT/JP2000/005220 WO2001011044A1 (fr) 1999-08-05 2000-08-03 Antigene de tumeur

Publications (1)

Publication Number Publication Date
ATE464383T1 true ATE464383T1 (de) 2010-04-15

Family

ID=16777163

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00949982T ATE464383T1 (de) 1999-08-05 2000-08-03 Tumor antigen

Country Status (9)

Country Link
US (1) US7465452B2 (de)
EP (1) EP1207199B1 (de)
JP (1) JP4051602B2 (de)
AT (1) ATE464383T1 (de)
AU (1) AU6318300A (de)
CA (1) CA2381348C (de)
DE (1) DE60044193D1 (de)
ES (1) ES2340357T3 (de)
WO (1) WO2001011044A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2003020306A1 (ja) * 2001-08-29 2004-12-16 伊東　恭悟 脱感作剤
US20060240026A1 (en) * 2003-08-05 2006-10-26 Green Peptide Co., Ltd. Preventing and/or remedy hematopoietic tumor
JP4579581B2 (ja) * 2003-12-08 2010-11-10 株式会社グリーンペプタイド 副甲状腺ホルモン関連タンパク質のｈｌａ−ａ２４またはｈｌａ−ａ２結合ペプチド
JP4721903B2 (ja) * 2004-01-29 2011-07-13 大日本住友製薬株式会社 新規腫瘍抗原蛋白質及びその利用
ES2714200T3 (es) 2007-09-18 2019-05-27 Brightpath Biotherapeutics Co Ltd Composición inductora de CTL
TWI580431B (zh) * 2008-08-19 2017-05-01 腫瘤療法 科學股份有限公司 Ｈｉｇ２與ｕｒｌｃ１０抗原決定位胜肽以及含此胜肽之疫苗
WO2012005161A1 (ja) 2010-07-07 2012-01-12 株式会社グリーンペプタイド がんペプチドワクチン
CN105008399B (zh) 2013-03-08 2018-09-28 大鹏药品工业株式会社 新型的具有5个连接的ctl表位的肽
WO2014162962A1 (ja) * 2013-04-01 2014-10-09 学校法人 久留米大学 腫瘍抗原ペプチド
HUE050164T2 (hu) * 2013-10-21 2020-12-28 Taiho Pharmaceutical Co Ltd Új négy-CTL epitóp-kapcsolt peptid
JP2021054720A (ja) * 2018-01-23 2021-04-08 学校法人 久留米大学 抗Ｌｃｋ−４８６抗体およびこれを含むがん治療用組成物
EP3815711A4 (de) 2018-06-29 2022-08-10 Taiho Pharmaceutical Co., Ltd. Antitumormittel und verfahren zu dessen beurteilung
EP4082563A4 (de) 2019-12-26 2024-02-28 Taiho Pharmaceutical Co., Ltd. Mittel zur postoperativen adjuvanten therapie

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5250431A (en) * 1988-06-13 1993-10-05 Dana-Farber Cancer Institute, Inc. Alteration of the interaction of a T-cell receptor with a proteintyrosine kinase
US5734023A (en) * 1991-11-19 1998-03-31 Anergen Inc. MHC class II β chain/peptide complexes useful in ameliorating deleterious immune responses
US5962224A (en) * 1995-12-19 1999-10-05 Dana-Farber Cancer Institute Isolated DNA encoding p62 polypeptides and uses therefor
AU7228398A (en) * 1997-04-11 1998-11-11 John P. Robarts Research Institute, The Lck serine phosphorylation assay for t-cell activation and activation-induced cell death
US6635623B1 (en) * 1997-06-13 2003-10-21 Baylor College Of Medicine Lipoproteins as nucleic acid vectors
JPWO2003020306A1 (ja) 2001-08-29 2004-12-16 伊東　恭悟 脱感作剤
JPWO2003037917A1 (ja) 2001-10-30 2005-02-17 伊東　恭悟 腫瘍抗原

Also Published As

Publication number Publication date
EP1207199A1 (de) 2002-05-22
US7465452B2 (en) 2008-12-16
JP4051602B2 (ja) 2008-02-27
CA2381348A1 (en) 2001-02-15
AU6318300A (en) 2001-03-05
CA2381348C (en) 2009-10-06
EP1207199B1 (de) 2010-04-14
DE60044193D1 (en) 2010-05-27
WO2001011044A1 (fr) 2001-02-15
ES2340357T3 (es) 2010-06-02
EP1207199A4 (de) 2002-11-27
US20020128201A1 (en) 2002-09-12

Similar Documents

Publication Publication Date Title
EP1306431A4 (de) Tumorantigen
DE60044193D1 (en) Tumor antigen
ATE136908T1 (de) Peptide und antikörper, die die integrin- ligandbindung inhibieren
IL153996A0 (en) Polypeptides containing at least a portion of an ovarian carcinoma protein, polynucleotides encoding the same and pharmaceutical compositions containing the same
AU4110001A (en) Polypeptide inducing apoptosis
PT2248899E (pt) Proteína de ligação do receptor nogo
GB9811260D0 (en) Novel compounds
ATE451461T1 (de) Antigene polypeptide aus neisseria meningitidis, dafür kodierende polynukleotide und entsprechende schützende antikörper
WO1999057277A3 (en) Basb019 proteins and genes from moraxella catarrhalis, antigens, antibodies, and uses
ID27162A (id) Peptida antigen tumor yang dibatasi hla-a2 yang berasal dari sart-1
IL139951A0 (en) Basbo27 proteins and genes from moraxella catarrhalis, intigens, antibodies and uses
GB9810285D0 (en) Novel compounds
ATE312922T1 (de) Moraxella catarrhalis polynukleotide und polypeptide
ATE397069T1 (de) Basb205 polypeptide und dafür kodierende polynukleotide
WO1999064448A3 (en) Moraxella catarrhalis pilq proteins
HK1047943A1 (zh) 黏膜炎莫拉氏菌basb114抗原及其用途
GB9918208D0 (en) Novel compounds
DE60019614D1 (de) Moraxella catarrhalis antigen basb117
ATE515511T1 (de) Nicht-typisierbare haemophilus influenzae basb201 polypeptide und polynukleotide und deren verwendungen
ATE293692T1 (de) Moraxella catarrhalis antigen basb120
WO2001009331A3 (en) Moraxella catarrhalis antigen basb125
WO2001009330A3 (en) Moraxella catarrhalis antigen basb121
DE60035788D1 (de) Polypeptide aus moraxella (branhamella) catarrhalis
GB9914945D0 (en) Novel compounds

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties